JUL 31, 2018 10:06 PM PDT

DNA For Drug Development?

WRITTEN BY: Nouran Amin

Genetic data of individuals who were customers of DNA testing service for the purpose of understanding their ancestry and genetic history, such as the company 23andME, could now be utilized for the development of new drugs.

23andMe, the home DNA testing service, announced a 4-year deal with pharmaceutical company GlaxoSmithKline (GSK), giving the manufacturer exclusive rights to genetic data of 23andMe's customers. "I started 23andMe with the belief that by getting people interested in learning about themselves and participating in research, we would all benefit," says Anne Wojcicki, CEO of 23andMe. "Today is an important milestone in how 23andMe will be able to impact the lives of those with disease and how we will be able to improve the future of healthcare.” However, this did not happen without permission, 23andMe users were asked if they agree to participants of future scientific research, an opt-in clause that has extended into an active drug discovery research project. “Customers can opt in or out at any time if they don't wish to participate in the research,” Wojcicki wrote in a blog post. “Ideally, the partnership will accelerate the development of pharmaceutical breakthroughs and advance the company's mission of improving healthcare.”

According to a GSK announcement, the collaboration will place a focused effort on the discovery of precision medicines based purely on genetic data. More specifically, identifying patient subgroups that will likely benefit and respond to targeted treatments, as well as more efficiently recruiting patients with certain diseases to participate in clinical studies. Additionally, the announcement explained that over 80 percent of 23andMe’s customer base has agreed to participate in research. Now, a gene called LRRK2 in the first project between the collaboration of GSK and 23andMe, is being examined in the pre-clinical phase that serves as a potential way to develop new drugs for treating Parkinson's disease.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 21, 2020
Microbiology
A Fast, Cheap Way to See if Two Antibiotics Work Together
SEP 21, 2020
A Fast, Cheap Way to See if Two Antibiotics Work Together
When a person has a bacterial infection, doctors can prescribe antibiotics. Some antibiotics combos can work better than ...
OCT 06, 2020
Cardiology
A New Heart Drug Taken from a Yellow Dye
OCT 06, 2020
A New Heart Drug Taken from a Yellow Dye
Cardiovascular disease is an ever-present issue in the modern world.  One of the most unfortunate cardiovascular ev ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
OCT 06, 2020
Drug Discovery & Development
Drug For A Severe E. Coli Infection
OCT 06, 2020
Drug For A Severe E. Coli Infection
Escherichia coli, known as E. coli, is a popular bacterium associated with food poisoning and depending on the strain ca ...
OCT 10, 2020
Drug Discovery & Development
Fishnet of Nanoparticles Traps Drug Molecules
OCT 10, 2020
Fishnet of Nanoparticles Traps Drug Molecules
‘Fishnet’ Nanoparticles Traps Drug Molecules A team at Northwestern University have casted a net of nanopart ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
Loading Comments...